Cargando…
VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer
SIMPLE SUMMARY: The V-domain Ig suppressor of T-cell activation (VISTA) suppresses T-cell effector function, and has been investigated as an alternative immunotherapeutic target in several cancers. In this study, we found increased VISTA expression in pancreatic tumor cells to be associated with dec...
Autores principales: | Digomann, David, Strack, Johannes, Heiduk, Max, Plesca, Ioana, Rupp, Luise, Reiche, Charlotte, Nicolaus, Simone, Beer, Carolin, Sommer, Ulrich, Schmitz, Marc, Distler, Marius, Weitz, Jürgen, Seifert, Adrian M., Seifert, Lena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136841/ https://www.ncbi.nlm.nih.gov/pubmed/37190254 http://dx.doi.org/10.3390/cancers15082326 |
Ejemplares similares
-
TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer
por: Heiduk, Max, et al.
Publicado: (2023) -
LAG-3-Expressing Tumor-Infiltrating T Cells Are Associated with Reduced Disease-Free Survival in Pancreatic Cancer
por: Seifert, Lena, et al.
Publicado: (2021) -
Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer
por: Heiduk, Max, et al.
Publicado: (2022) -
Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma
por: Plesca, Ioana, et al.
Publicado: (2022) -
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer
por: Digomann, David, et al.
Publicado: (2023)